Critical to the success of a world-class institution like Joslin is solid leadership. To maintain the Center's level of excellence in diabetes research, care and education; Joslin's Boards of Trustees and Overseers work in tandem with the executive team.
Together, executives and volunteers ensure Joslin is grounded on a steady foundation, yet has the freedom to create new knowledge – a hallmark of this one-of-a-kind Center.
Publicly representing the institution, Joslin's Board of Trustees comprises local, national and international philanthropic leaders who have a special connection to Joslin and a shared goal of a future without diabetes.
Board of Trustees
Peter S. Amenta, M.D., Ph.D. - University of Medicine and Dentistry of NJ, Robert Wood Johnson Medical School
Michael Astrue - Former U.S. Commissioner of Social Security
John J. Cook, Jr. - Managing Director, Seaward Management Corp.
Nathaniel S. Gardiner - Edwards Wildman Palmer LLP
James Geraghty - Entrepreneur-in-Residence, Third Rock Ventures
Morella M. Grossmann
Roberta Herman, M.D. - Former Chief Operating Officer, Harvard Pilgrim Health Care, Inc.
Jessica Hopfield, Ph. D. - Former Partner, McKinsey & Company
Ralph M. James, Chairperson of the Board - Executive Director, External Relations, Harvard Business School
Ann M. Lagasse
James L. Peterson
Geoffrey S. Rehnert - Founder and Co-CEO, Audax Group
Mark E. Russell - Vice President, Raytheon Company
Richard A. Smith
John L. Brooks III - President and CEO, Joslin Diabetes Center
Robert A. Gabbay, M.D. - Chief Medical Officer and Senior Vice President, Joslin Diabetes Center
George L. King, M.D. - Senior Vice President and Chief Scientific Officer, Joslin Diabetes Center
Charles H. Hood
Patrick H. O’Neill
Kenneth E. Quickel, M.D., former President, Joslin Diabetes Center
A full version of the Fiscal 2012 Tax Return is available to review in person at the Joslin Diabetes Center.
Page last updated: April 20, 2014